Actively Recruiting
to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban
Led by Onconic Therapeutics Inc. · Updated on 2025-12-04
96
Participants Needed
1
Research Sites
19 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban
CONDITIONS
Official Title
to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy subjects aged 19 years to under 65 years at screening
- Subjects weighing at least 50 kg (or at least 45 kg for females) with a BMI between 18.0 and 30.0 kg/m2
- Subjects who have voluntarily agreed to participate and provided written informed consent after understanding the trial details
You will not qualify if you...
- History of significant disease in liver, kidneys, digestive, respiratory, musculoskeletal, endocrine, neuropsychiatric, hematopoietic, oncological, or cardiovascular systems
- History of significant bleeding or bleeding disorders such as hemophilia
- History of gastrointestinal disorders (e.g., Crohn's disease, ulcerative disease) or surgeries affecting drug absorption (excluding appendectomy, hernia repair, endoscopic polypectomy, hemorrhoidectomy, fissure, or fistula surgery)
- Presence of hereditary disorders like galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption
- Abnormal laboratory test results on screening
- Judged unsuitable for study participation by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cha University Bundang Medical Center
Seongnam-si, Gyeonggi-do, South Korea, 13496
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here